Cargando…
Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor
BACKGROUND: Mesenchymal Progenitor/Stem Cells (MSC) respond to homing cues providing an important mechanism to deliver therapeutics to sites of injury and tumors. This property has been confirmed by many investigators, however, the efficiency of tumor homing needs to be improved for effective therap...
Autores principales: | Komarova, Svetlana, Roth, Justin, Alvarez, Ronald, Curiel, David T, Pereboeva, Larisa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883983/ https://www.ncbi.nlm.nih.gov/pubmed/20500878 http://dx.doi.org/10.1186/1757-2215-3-12 |
Ejemplares similares
-
Derivation of a Myeloid Cell-Binding Adenovirus for Gene Therapy of Inflammation
por: Alberti, Michael O., et al.
Publicado: (2012) -
Carcinoma-Associated Mesenchymal Stem Cells Promote Chemoresistance in Ovarian Cancer Stem Cells via PDGF Signaling
por: Raghavan, Shreya, et al.
Publicado: (2020) -
Biopolymer Hydrogel Scaffold as an Artificial Cell Niche for Mesenchymal Stem Cells
por: Egorikhina, Marfa N., et al.
Publicado: (2020) -
Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells
por: Pereboeva, Larisa, et al.
Publicado: (2016) -
Blocking PD1/PDL1 Interactions Together with MLN4924 Therapy is a Potential Strategy for Glioma Treatment
por: Filippova, Natalia, et al.
Publicado: (2018)